Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bio-Gene Technology Ltd. made significant strides in its commercial development efforts during Q1 FY25, highlighted by a new partnership with Envu to explore Flavocide® for mosquito management and successful pilot-scale production by Rallis India. These developments position Bio-Gene for future large-scale manufacturing and regulatory approval in Australia, anticipated by December 2025. The company is actively pursuing further commercial partnerships to expand Flavocide and Qcide® into various sectors, enhancing its market potential.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.